Počet záznamů: 1

Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative Activity

  1. 1.
    0368592 - UEB-Q 2012 RIV US eng J - Článek v odborném periodiku
    Jorda, Radek - Havlíček, Libor - McNae, I. W. - Walkinshaw, M. D. - Voller, Jiří - Šturc, Antonín - Navrátilová, Jana - Kuzma, Marek - Mistrik, M. - Bártek, J. - Strnad, Miroslav - Kryštof, Vladimír
    Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine: Evaluation of a Novel Selective Inhibitor of Cyclin-Dependent Kinases with Antiproliferative Activity.
    Journal of Medicinal Chemistry. Roč. 54, č. 8 (2011), s. 2980-2993 ISSN 0022-2623
    Grant CEP: GA ČR GA301/02/0475; GA ČR GA301/08/1649; GA MŠk ED0007/01/01
    Výzkumný záměr: CEZ:AV0Z50380511; CEZ:AV0Z50200510
    Klíčová slova: STRUCTURE-GUIDED DESIGN * DNA-END RESECTION * DOWN-REGULATION * R-ROSCOVITINE * CELL-CYCLE
    Kód oboru RIV: ED - Fyziologie
    Impakt faktor: 5.248, rok: 2011

    Inhibition of cyclin-dependent kinases (CDKs) with. small molecules has been suggested as a strategy for treatment of cancer, based on deregulation of CDKs commonly found in many types of human tumors. Here, a new potent CDK2 inhibitor with pyrazolo[4,3-d]pyrimidine scaffold has been synthesized, characterized, and evaluated in cellular and biochemical assays. 7-Benzylamino-5(R)-[2-(hydroxymethyl)-propyl]amino-3-isopropyl-1(2)H-pyrazolo[4,3-d]pyrimidine, compound 7, was prepared as a bioisostere of the well-known CDK inhibitor roscovitine. An X-ray crystal structure of compound 7 bound to CDK2 has been determined, revealing a binding mode similar to that of roscovitine.
    Trvalý link: http://hdl.handle.net/11104/0202891
    Název souboruStaženoVelikostKomentářVerzePřístup
    2011_Jorda_JOURNAL OF MEDICINAL CHEMISTRY_2980.pdf52.9 MBJinápovolen